Atossa Therapeutics (Germany) Probability of Future Stock Price Finishing Over 10.46
| YAG2 Stock | EUR 1.17 0.06 5.41% |
Atossa |
Atossa Therapeutics Target Price Odds to finish over 10.46
The tendency of Atossa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 10.46 or more in 90 days |
| 1.17 | 90 days | 10.46 | close to zero percent |
Based on a normal probability distribution, the odds of Atossa Therapeutics to move over € 10.46 or more in 90 days from now is close to zero percent (This Atossa Therapeutics probability density function shows the probability of Atossa Stock to fall within a particular range of prices over 90 days) . Probability of Atossa Therapeutics price to stay between its current price of € 1.17 and € 10.46 at the end of the 90-day period is about 87.51 .
Assuming the 90 days trading horizon Atossa Therapeutics has a beta of 0.47. This entails as returns on the market go up, Atossa Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Atossa Therapeutics will be expected to be much smaller as well. Additionally Atossa Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Atossa Therapeutics Price Density |
| Price |
Predictive Modules for Atossa Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Atossa Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Atossa Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Atossa Therapeutics is not an exception. The market had few large corrections towards the Atossa Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Atossa Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Atossa Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | 0.47 | |
σ | Overall volatility | 0.08 | |
Ir | Information ratio | -0.02 |
Atossa Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Atossa Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Atossa Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Atossa Therapeutics generated a negative expected return over the last 90 days | |
| Atossa Therapeutics may become a speculative penny stock | |
| Atossa Therapeutics has high historical volatility and very poor performance | |
| Atossa Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (20.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atossa Therapeutics has accumulated about 131.49 M in cash with (16.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04. |
Atossa Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Atossa Stock often depends not only on the future outlook of the current and potential Atossa Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atossa Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 126.6 M |
Atossa Therapeutics Technical Analysis
Atossa Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Atossa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Atossa Therapeutics. In general, you should focus on analyzing Atossa Stock price patterns and their correlations with different microeconomic environments and drivers.
Atossa Therapeutics Predictive Forecast Models
Atossa Therapeutics' time-series forecasting models is one of many Atossa Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Atossa Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Atossa Therapeutics
Checking the ongoing alerts about Atossa Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Atossa Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Atossa Therapeutics generated a negative expected return over the last 90 days | |
| Atossa Therapeutics may become a speculative penny stock | |
| Atossa Therapeutics has high historical volatility and very poor performance | |
| Atossa Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (20.61 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Atossa Therapeutics has accumulated about 131.49 M in cash with (16.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04. |
Other Information on Investing in Atossa Stock
Atossa Therapeutics financial ratios help investors to determine whether Atossa Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Atossa with respect to the benefits of owning Atossa Therapeutics security.